CMI_LatestReportOrientedBlogs

Epileptic Seizures Treatment Market Epilepsy is a brain condition that affects people of all ages and is a chronic non-communicable disease. Epilepsy can strike at any age, however it most commonly strikes children or persons over the age of 60. Seizures have varying effects on people depending on which section of the brain is engaged. Uncontrollable jerking and shaking, known as a 'fit,' loss of awareness and staring blankly into space, stiffness, peculiar feelings in the stomach, unusual smell or taste, tingling sensation in the arms or legs, and collapse are all possible epilepsy symptoms. Anti-epileptic medication therapy, brain surgery, vagus nerve stimulation, deep brain stimulation, and the ketogenic diet are the most prevalent treatments for epileptic seizures. The need for epilepsy therapy remained unchanged during the COVID-19 pandemic, despite the fact that epilepsy and COVID-19 infection do not appear to be linked. There is no concrete proof that a coronavirus inf

A Smartphone is a mobile phone with advanced features and capabilities in addition to standard functions such as texting and making phone calls. Users using fifth-generation smartphones have access to high-speed networks and a better data-transfer experience. Furthermore, 5G devices provide high bandwidth and low latency, which can improve user experience in areas such as online video streaming and seamless video calling, as well as virtual and augmented reality gaming. 5G Smartphone During the projected period, the availability of 5G smartphones with reduced power consumption is likely to fuel market development. Furthermore, rising disposable income and the adoption of IoT linked devices are likely to propel market growth during the projection period. According to Coherent Market Insights, The global 5G smartphone market was valued at US$ 13.4 Bn in 2019 and is expected to reach US$ 4,032.3 Bn by 2027 at a CAGR of 124.9% between 2020 and 2027. The market will rise due to reasons

  Preimplantation Genetic Diagnosis Patients who choose in vitro fertilisation, Preimplantation Genetic Diagnosis is performed to test for aneuploidy in situations with poor prognosis. It is also useful in the identification of inherited single gene illnesses, X-linked diseases, and, more recently, late-onset diseases. Preimplantation Genetic Diagnosis is a procedure for discovering genetic problems in IVF embryos before they become pregnant. PGD is the process of testing embryos for genetic abnormalities. Current post-conception diagnostic methods are being replaced by PGD. Preimplantation Genetic Diagnosis is a technology used in IVF genetic testing that allows for a more thorough analysis of embryos than just their appearance. By completing embryo genetic testing, PGD considerably decreases the risks of generating unhealthy embryos, which is a major driving factor for market expansion. Furthermore, it improves the odds of having a healthy pregnancy. Furthermore, variables such as

  Immuno Oncology Assays Next-generation sequencing applications include immuno-oncology Assays. For real-time measurements or continuous analysis, immuno oncology tests assist to preserve cell shape as well as cell health. T cell assays, Tumor killing assays, Tumor cell assays, Natural killer cell assays, Macrophage assays, and Dendritic cell assays are among the immuno oncology Assays available. Immuno Oncology Assays Market Drivers- During the projected period, new product releases are likely to drive the immuno oncology assays market forward. For example, Roche Diagnostics released the VENTANA HER2 Dual ISH DNA Probe Cocktail test in April 2019 for detecting the biomarker human epidermal growth factor receptor 2 (HER2) in breast and gastric malignancies. In addition, leading market players are focusing on releasing innovative immuno oncology assays, which is projected to propel the immune oncology assays market forward. For example, in August 2018, Thermo Fisher Scientific r

  Spirometer A spirometer is a device that measures the amount of air that enters and exits the lungs during breathing to determine lung capacity. In a spirometer test, the patient inhales deeply into a spirometer tube connected to a reader, which measures and records the lungs' air capacity. Any variation from the typical spirometer readings shows that the lungs are dysfunctional. Cystic fibrosis, pulmonary fibrosis, emphysema, chronic bronchitis, asthma, bronchiectasis, and other chronic lung illnesses may all be diagnosed with a spirometer. The global Spirometer Market is estimated to be valued at US$ 958.0 million in 2021 and is expected to exhibit a CAGR of 9.5% over the forecast period (2021-2028). In the case of chronic pulmonary disorders, a spirometer can also be used to practise breathing exercises and avoid the buildup of mucus and fluid in the lungs. A spirometer can also be used to evaluate lung function before undergoing surgery such as bariatric surgery, knee repl